These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2155492)

  • 1. Ganciclovir in the treatment of severe cytomegalovirus disease in liver transplant patients.
    Salmela K; Höckerstedt K; Lautenschlager I; Eklund B; Isoniemi H; Holmberg C; Ahonen J
    Transplant Proc; 1990 Feb; 22(1):238-40. PubMed ID: 2155492
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of transplant rejection in the presence of cytomegalovirus viremia.
    O'Hair DP; Johnson CP; Roza AM; Adams MB
    Transplant Proc; 1990 Aug; 22(4):1815-7. PubMed ID: 2167537
    [No Abstract]   [Full Text] [Related]  

  • 3. Ganciclovir therapy for viral disease in liver transplant recipients.
    Stratta R; Shaefer M; Markin R; Bradshaw K; Donovan J; Wood R; Langnas A; Reed E; Woods G; Zetterman R
    Transplant Proc; 1991 Jun; 23(3):1968. PubMed ID: 1648277
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective study of the incidence, timing, significance, risk factors, and outcome of cytomegalovirus infection in liver transplant patients with double-drug immunosuppression and no prophylactic antiviral therapy.
    Sanchez-Turrión V; Cuervas-Mons V; Portero F; Barrios C; Garrido A; Albillos A
    Transplant Proc; 1993 Apr; 25(2):1786. PubMed ID: 8385824
    [No Abstract]   [Full Text] [Related]  

  • 5. Ganciclovir therapy for cytomegalovirus disease in liver transplant recipients.
    Shaefer MS; Stratta RJ; Markin RS; Cushing KA; Woods GL; Reed EC; Wood RP; Langnas AN; Shaw BW
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1515-6. PubMed ID: 1846475
    [No Abstract]   [Full Text] [Related]  

  • 6. [Should recurrent Cytomegalovirus infections in patients with liver transplantation be treated?].
    Tarp BD; Astrup LB
    Ugeskr Laeger; 1997 May; 159(22):3413-6. PubMed ID: 9199030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
    J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of cytomegalovirus disease in liver transplant patients treated prophylactically with combination cytomegalovirus hyperimmune globulin and ganciclovir.
    Prian GW; Koep LJ
    Transplant Proc; 1994 Oct; 26(5 Suppl 1):54-5. PubMed ID: 7940977
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation.
    Slifkin M; Ruthazer R; Freeman R; Bloom J; Fitzmaurice S; Fairchild R; Angelis M; Cooper J; Barefoot L; Rohrer R; Snydman DR
    Liver Transpl; 2005 Dec; 11(12):1597-602. PubMed ID: 16315314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of CMV-DNA in peripheral blood leukocytes of liver transplant patients after ganciclovir treatment.
    Loginov R; Höckerstedt K; Lautenschlager I
    Arch Virol; 2003 Jul; 148(7):1269-74. PubMed ID: 12827460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
    Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
    Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal cytomegalovirus hepatitis: to treat or not to treat with ganciclovir.
    Vancíková Z; Kucerová T; Pelikán L; Zikmundová L; Priglová M
    J Paediatr Child Health; 2004 Aug; 40(8):444-8. PubMed ID: 15265185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation.
    Stein DS; Verano AS; Levandowski RA
    Am J Gastroenterol; 1988 Jun; 83(6):684-6. PubMed ID: 2837082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with ganciclovir and intravenous IgG for cytomegalovirus infections in pediatric liver transplant recipients.
    Megison SM; Andrews WS
    Transplantation; 1991 Jul; 52(1):151-4. PubMed ID: 1650042
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of early treatment of cytomegalovirus infection by ganciclovir in renal transplant recipients.
    Rondeau E; Farquet C; Ruedin P; Fries D; Sraer JD
    Transplant Proc; 1990 Aug; 22(4):1813-4. PubMed ID: 2167536
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
    Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative CMV-antigenemia test in the diagnosis of CMV infection and in the monitoring of response to antiviral treatment in liver transplant recipients.
    Lautenschlager I; Höckerstedt K; Salmela K
    Transplant Proc; 1994 Jun; 26(3):1719-20. PubMed ID: 8030100
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
    Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
    Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.